title: Influence of selected formulation variables on the preparation of enzyme-entrapped Eudragit S100 microspheres.
abstract: The aim of this work is to study the influence of formulation parameters in the preparation of sustained release enzyme-loaded Eudragit S100 microspheres by emulsion solvent diffusion technique. A 3(2) full factorial experiment was designed to study the effects of the amount of solvent (dichloromethane) and stabilizers (Tween 20, 40, or 80) on the drug content and microsphere size. The results of analysis of variance test for both effects indicated that the test is significant. The effect of amount of stabilizer was found to be higher on both responses (SS(Y1) = 45.60; SS(Y2) = 737.93), whereas solvent concentration comparatively produced significant effect on the size of microspheres (SS(Y1) = 0.81; SS(Y2) = 358.83). Scanning electron microscopy of microspheres with maximum drug content (2.5 mL dichloromethane and 0.1 mL Tween 80) demonstrated smooth surface spherical particles with mean diameter of 56.83 +/- 2.88 microm. The effect of formulation variables on the integrity of enzyme was confirmed by in vitro proteolytic activity. The enteric nature of microspheres was evaluated and results demonstrated ~6% to 7% release of enzyme in acidic medium. The release of enzyme from microspheres followed Higuchi kinetics. In phosphate buffer, microspheres showed an initial burst release of 20.34% +/- 2.35% in 1 hour with additional 58.79% +/- 4.32% release in the next 5 hours. Three dimensional response graphs were presented to visualize the effect of independent variables on the chosen response. Thus, Eudragit S100 microspheres can be successfully prepared for oral delivery of enzymes with desirable characters in terms of maximum loading and diffusion release pattern.
authors.affiliation: Institute of Pharmacy, Pt. Ravishankar Shukla University, Raipur, C.G.-492010, India.
authors.forename: Manju
authors.initials: M
authors.lastname: Rawat
authors.forename: Shailendra
authors.initials: S
authors.lastname: Saraf
authors.forename: Swarnlata
authors.initials: S
authors.lastname: Saraf
mesh_terms: D000284:Administration, Oral; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000737:chemistry*; D002364:Caseins / Q000737:chemistry; D002626:Chemistry, Pharmaceutical; D003692:Delayed-Action Preparations; D004058:Diffusion; D004337:Drug Carriers; D004339:Drug Compounding; D005079:Excipients / Q000737:chemistry*; D006863:Hydrogen-Ion Concentration; D006868:Hydrolysis; D007700:Kinetics; D008752:Methylene Chloride / Q000737:chemistry; D008863:Microspheres; D008956:Models, Chemical; D015233:Models, Statistical; D010316:Particle Size; D010447:Peptide Hydrolases / Q000008:administration & dosage / Q000737:chemistry*; D011109:Polymethacrylic Acids / Q000737:chemistry*; D011136:Polysorbates / Q000737:chemistry; D012107:Research Design; D012995:Solubility; D012997:Solvents / Q000737:chemistry*; D013499:Surface Properties; D013678:Technology, Pharmaceutical / Q000379:methods
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D002364:Caseins; D003692:Delayed-Action Preparations; D004337:Drug Carriers; D005079:Excipients; D011109:Polymethacrylic Acids; D011136:Polysorbates; D012997:Solvents; C038300:methylmethacrylate-methacrylic acid copolymer; D008752:Methylene Chloride; D010447:Peptide Hydrolases; C022640:serratiopeptidase; C068430:polysorbate 40